Skip to main content
MIZUHO MEDY CO.,LTD. logo

MIZUHO MEDY CO.,LTD. — Investor Relations & Filings

Ticker · 4595 ISIN · JP3885900005 T Manufacturing
Open in API
Filings indexed 59 across all filing types
Latest filing 2026-03-26 Regulatory Filings
Country JP Japan
Listing T 4595

About MIZUHO MEDY CO.,LTD.

https://www.mizuho-m.co.jp/en/

MIZUHO MEDY CO.,LTD. is a company that specializes in the research, development, manufacture, and sale of in-vitro diagnostic (IVD) products. The company's portfolio is centered on two main technologies: rapid immunoassays and nucleic acid amplification tests. Its rapid immunoassay product line includes the 'Quick Chaser' series for the detection of infectious diseases such as influenza, RSV, and SARS-CoV-2, as well as consumer-oriented products like pregnancy and ovulation test kits. In the molecular diagnostics segment, the company offers nucleic acid amplification test products, including the 'Smart Gene®' system, and develops related equipment like fully automated gene analysis instruments. Mizuho Medy serves various sectors, including medical diagnostics, research, and agriculture.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 80% confidence The document is a short statutory “confirmation letter” (確認書) filed under Japan’s Financial Instruments and Exchange Act Section 24-4-2 to the Fukuoka Finance Bureau. It simply certifies the proper disclosure of the 49th-term securities report and does not contain the financial statements themselves. It is not the annual report (10-K) but a regulatory submission that does not fit other specific categories, so it defaults to the fallback “Regulatory Filings (RNS).”
2026-03-26 Japanese
有価証券報告書－第49期(2025/01/01－2025/12/31)
Annual Report Classification · 100% confidence The document is a formal 'Yuka Shoken Hokokusho' (Securities Report) filed with the Fukuoka Local Finance Bureau in Japan. It contains comprehensive financial data, business history, and management information for the fiscal year ending December 31, 2025. This is the Japanese equivalent of a 10-K annual report. FY 2025
2026-03-26 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification confirming the accuracy of the contents of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type like an interim/semi-annual report. H1 49
2025-08-08 Japanese
半期報告書－第49期(2025/01/01－2025/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed with the Fukuoka Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, including the balance sheet, for the interim period (January 1, 2025, to June 30, 2025). It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-08 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled '臨時報告書' (Extraordinary Report) and explicitly states in Section 1 that it is being submitted based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act, following the resolutions made at the Annual General Meeting (AGM) held on March 28, 2025. Section 2 details the resolutions, including dividend approval (剰余金の処分の件) and the election of directors (取締役７名選任の件), along with the voting results (賛成, 反対, 棄権). This structure—a formal report detailing the outcomes of a shareholder meeting—is characteristic of reporting the results of a general meeting. Since the content is the official results of the vote, the most appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). It is not the AGM presentation itself (AGM-R), nor is it a proxy solicitation document (PSI).
2025-04-02 Japanese
内部統制報告書－第48期(2024/01/01－2024/12/31)
Governance Information Classification · 100% confidence The document explicitly states in the header section (【提出書類】) that it is an "内部統制報告書" (Internal Control Report). It references the Financial Instruments and Exchange Act (金融商品取引法) and details the scope, criteria (based on the Financial Accounting Standards Board's framework), and the conclusion of the assessment of internal controls over financial reporting as of the fiscal year-end (2024年12月31日). This content aligns perfectly with the definition of an Audit Report / Information (AR), which covers internal or regulatory stress tests and applied accounting principles, although this specific report focuses on internal controls rather than an external audit opinion. Given the options, 'AR' (Audit Report / Information) is the closest fit for a formal report detailing internal control effectiveness assessment, as opposed to a full Annual Report (10-K) or a simple announcement (RPA/RNS). The document length (1731 chars) suggests it is the report itself, not just an announcement of it.
2025-03-31 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.